EX-4.4 7 d195054dex44.htm EX-4.4 SHAREHOLDERS’ AGREEMENTShareholders Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionTHIS SHAREHOLDERS’ AGREEMENT (this “Agreement”) is entered into as of March 1, 2014 by and among iKang Healthcare Group, Inc., an exempted company incorporated with limited liability in the Cayman Islands (the “Company”), iKang Guobin Healthcare Group, Inc., a BVI business company organized and existing under the Laws of the British Virgin Islands, (“iKang BVI”) each of the Company Group Holdcos (as defined herein), each of the Founders (as defined herein), each of the holders of Series A Preferred Shares as set forth in Schedule A hereto (each, a “Preferred A Holder”), each of the holders of Series B Preferred Shares as set forth in Schedule B hereto (each, a “Preferred B Holder”), each of the holders of Series C-1 Preferred Shares, Series C-2 Preferred Shares and Series C-3 Preferred Shares as set forth in Schedule C hereto (each, a “Preferred C Holder”), each of the holders of Series D-1 Preferred Shares and Series D-2 Preferred Shares as respectively set forth in Schedule D-1 and S
SHAREHOLDERS’ AGREEMENTShareholders Agreement • March 21st, 2014 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine • New York
Contract Type FiledMarch 21st, 2014 Company Industry JurisdictionTHIS SHAREHOLDERS’ AGREEMENT (this “Agreement”) is entered into as of March 1, 2014 by and among iKang Healthcare Group, Inc., an exempted company incorporated with limited liability in the Cayman Islands (the “Company”), iKang Guobin Healthcare Group, Inc., a BVI business company organized and existing under the Laws of the British Virgin Islands, (“iKang BVI”) each of the Company Group Holdcos (as defined herein), each of the Founders (as defined herein), each of the holders of Series A Preferred Shares as set forth in Schedule A hereto (each, a “Preferred A Holder”), each of the holders of Series B Preferred Shares as set forth in Schedule B hereto (each, a “Preferred B Holder”), each of the holders of Series C-1 Preferred Shares, Series C-2 Preferred Shares and Series C-3 Preferred Shares as set forth in Schedule C hereto (each, a “Preferred C Holder”), each of the holders of Series D-1 Preferred Shares and Series D-2 Preferred Shares as respectively set forth in Schedule D-1 and S